Demographic data, operative time, hospital stay, operative blood loss, post-operative pain, wound healing time and patient's satisfaction were recorded.
They also had the shortest hospital stay, operative blood loss and postoperative pain (p<0.001).
There was a statistically significant difference between the two groups with respect to duration of hospital stay, operative time and blood loss.
Direct costs relate to health care costs and include those relating to the hospital stay, operative procedure and treatment-related complications.
Details of reasons for visits were given, which allowed for exclusion of double counting of in-patient stay (operative procedure and reoperations), and outpatient visits for radiotherapy or chemotherapy, which were excluded from the analysis.
There was a trend towards shorter ICU stay for operative patients.
There was a trend towards shorter ICU stay for operative patients (12.3 ± 8.5 versus 9.0 ± 4.3 days, P = 0.076).
Secondary outcomes are subjective improvement on urogenital symptoms and quality of life (assessed by disease-specific and general quality of life questionnaires), complications following surgery, hospital stay, post-operative recovery, sexual functioning and costs-effectiveness.
Secondary endpoints of this study include: subjective outcome and improvement in general and disease-specific quality of life, complications, hospital stay, post-operative recovery and sexual functioning after sacrospinous fixation or vaginal hysterectomy.
The SAVE U trial is designed to compare sacrospinous fixation with vaginal hysterectomy in the treatment of uterine prolapse stage 2 or higher in terms of prolapse recurrence, quality of life, complications, hospital stay, post-operative recovery and sexual functioning.
The objective of this study is to determine whether laparoscopic sacrohysteropexy in women with uterine descent stage 2 or higher improves outcome in terms of recurrence of prolapse, quality of life, complications, hospital stay, post-operative recovery, sexual functioning and costs-effectiveness compared to vaginal sacrospinous hysteropexy.
